Support is growing for increased collaboration between pharmaceutical companies and patients in research processes worldwide, according to a new report by healthcare intelligence company GBI Research.
Saskatchewan pharmacists are expected to receive provincially funded minor ailment assessment fees for four new ailments, bringing the total number to seven.